Diacetolol (BioDeep_00000275074)

   


代谢物信息卡片


Diacetolol

化学式: C16H24N2O4 (308.1735984)
中文名称: 外消旋二醋洛尔
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1
InChI: InChI=1S/C16H24N2O4/c1-10(2)17-8-14(21)9-22-16-6-5-13(18-12(4)20)7-15(16)11(3)19/h5-7,10,14,17,21H,8-9H2,1-4H3,(H,18,20)

描述信息

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist

同义名列表

1 个代谢物同义名

Diacetolol



数据库引用编号

11 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Brendan Le Daré, Sophie Allard, Renaud Bouvet, Alain Baert, Pierre-Marie Allard, Isabelle Morel, Thomas Gicquel. A case of fatal acebutolol poisoning: an illustration of the potential of molecular networking. International journal of legal medicine. 2020 Jan; 134(1):251-256. doi: 10.1007/s00414-019-02062-9. [PMID: 30997571]
  • Ali F Al-Ghamdi, Mohamed M Hefnawy, Abdulrahman A Al-Majed, Fatallah F Belal. Development of square-wave adsorptive stripping voltammetric method for determination of acebutolol in pharmaceutical formulations and biological fluids. Chemistry Central journal. 2012 Feb; 6(?):15. doi: 10.1186/1752-153x-6-15. [PMID: 22353684]
  • Hongliang Jiang, Christopher Randlett, Heiko Junga, Xiangyu Jiang, Qin C Ji. Using supported liquid extraction together with cellobiohydrolase chiral stationary phases-based liquid chromatography with tandem mass spectrometry for enantioselective determination of acebutolol and its active metabolite diacetolol in spiked human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2009 Jan; 877(3):173-80. doi: 10.1016/j.jchromb.2008.12.006. [PMID: 19109073]
  • Jari J Lilja, Kari Raaska, Pertti J Neuvonen. Effects of grapefruit juice on the pharmacokinetics of acebutolol. British journal of clinical pharmacology. 2005 Dec; 60(6):659-63. doi: 10.1111/j.1365-2125.2005.02489.x. [PMID: 16305592]
  • Hans H Maurer, Oliver Tenberken, Carsten Kratzsch, Armin A Weber, Frank T Peters. Screening for library-assisted identification and fully validated quantification of 22 beta-blockers in blood plasma by liquid chromatography-mass spectrometry with atmospheric pressure chemical ionization. Journal of chromatography. A. 2004 Nov; 1058(1-2):169-81. doi: . [PMID: 15595665]
  • Magali Delamoye, Charlotte Duverneuil, François Paraire, Philippe de Mazancourt, Jean-Claude Alvarez. Simultaneous determination of thirteen beta-blockers and one metabolite by gradient high-performance liquid chromatography with photodiode-array UV detection. Forensic science international. 2004 Apr; 141(1):23-31. doi: 10.1016/j.forsciint.2003.12.008. [PMID: 15066710]
  • S Abolfazl Mostafavi, Robert T Foster. Influence of cimetidine co-administration on the pharmacokinetics of acebutolol enantiomers and its metabolite diacetolol in a rat model: the effect of gastric pH on double-peak phenomena. International journal of pharmaceutics. 2003 Apr; 255(1-2):81-6. doi: 10.1016/s0378-5173(03)00037-1. [PMID: 12672604]
  • Jun Shik Choi, Jin Pil Burm. Pharmacokinetics of acebutolol and its main metabolite, diacetolol after oral administration of acebutolol in rabbits with carbon tetrachloride-induced hepatic failure. Archives of pharmacal research. 2002 Aug; 25(4):541-5. doi: 10.1007/bf02976615. [PMID: 12214869]
  • J Szymura-Oleksiak, M Walczak, J Bojarski, H Y Aboul-Enein. Enantioselective high performance liquid chromatographic assay of acebutolol and its active metabolite diacetolol in human serum. Chirality. 1999; 11(4):267-71. doi: 10.1002/(sici)1520-636x(1999)11:4<267::aid-chir2>3.0.co;2-j. [PMID: 10224653]
  • M Piquette-Miller, F Jamali. Effect of adjuvant arthritis on the disposition of acebutolol enantiomers in rats. Agents and actions. 1992 Nov; 37(3-4):290-6. doi: 10.1007/bf02028122. [PMID: 1295378]
  • M Piquette-Miller, R T Foster, C T Kappagoda, F Jamali. Effect of aging on the pharmacokinetics of acebutolol enantiomers. Journal of clinical pharmacology. 1992 Feb; 32(2):148-56. doi: 10.1002/j.1552-4604.1992.tb03820.x. [PMID: 1613125]
  • M Piquette-Miller, R T Foster, C T Kappagoda, F Jamali. Pharmacokinetics of acebutolol enantiomers in humans. Journal of pharmaceutical sciences. 1991 Apr; 80(4):313-6. doi: 10.1002/jps.2600800405. [PMID: 1865329]
  • V G Kukes, E T Gneushev, T Sh Mamedov, I A Gneusheva. [Acebutolol and diacetolol: their binding to plasma proteins and erythrocytes and secretion with the saliva]. Farmakologiia i toksikologiia. 1991 Jan; 54(1):53-5. doi: NULL. [PMID: 1860501]
  • M Piquette-Miller, R T Foster. High-performance liquid chromatographic determination of diacetolol enantiomers. Journal of chromatography. 1990 Nov; 533(?):300-3. doi: 10.1016/s0378-4347(00)82218-5. [PMID: 2081779]
  • J Mantz, G Blanchot, J Marty, R Farinotti, J H Trouvin, J Hazebroucq, J M Desmonts. Acebutolol and diacetolol plasma levels in patients undergoing myocardial revascularization with hypothermic cardiopulmonary bypass. Journal of cardiothoracic anesthesia. 1990 Oct; 4(5):577-81. doi: 10.1016/0888-6296(90)90407-7. [PMID: 2132136]
  • M J Boutroy, G Bianchetti, C Dubruc, P Vert, P L Morselli. To nurse when receiving acebutolol: is it dangerous for the neonate?. European journal of clinical pharmacology. 1986; 30(6):737-9. doi: 10.1007/bf00608227. [PMID: 3770068]
  • J R Ryan. Clinical pharmacology of acebutolol. American heart journal. 1985 May; 109(5 Pt 2):1131-6. doi: 10.1016/0002-8703(85)90697-0. [PMID: 2859776]
  • D R Abernethy, R M Arendt, D J Greenblatt. Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration. American heart journal. 1985 May; 109(5 Pt 2):1120-5. doi: 10.1016/0002-8703(85)90695-7. [PMID: 2859774]
  • G De Bono, C M Kaye, E Roland, A J Summers. Acebutolol: ten years of experience. American heart journal. 1985 May; 109(5 Pt 2):1211-3. doi: 10.1016/0002-8703(85)90712-4. [PMID: 2859785]
  • N V Fergusson, J G Dalgleish, D A Saunders. Acebutolol and oral surgery: plasma levels following a single oral dose. Annals of the Royal College of Surgeons of England. 1985 Mar; 67(2):124-6. doi: NULL. [PMID: 3883878]
  • U Borchard, D Hafner, C Hirth. In vitro studies on the pharmacological properties of diacetolol, the major metabolite of acebutolol in man. Archives internationales de pharmacodynamie et de therapie. 1985 Jan; 273(1):4-17. doi: . [PMID: 2860878]
  • M G Sankey, A Gulaid, C M Kaye. Preliminary study of the disposition in man of acebutolol and its metabolite, diacetolol, using a new stereoselective hplc method. The Journal of pharmacy and pharmacology. 1984 Apr; 36(4):276-7. doi: 10.1111/j.2042-7158.1984.tb04370.x. [PMID: 6144783]
  • A Roux, J F Henry, Y Fouache, N P Chau, M P Hervy, F Forette, J P Bourdarias, B Flouvat. A pharmacokinetic study of acebutolol in aged subjects as compared to young subjects. Gerontology. 1983; 29(3):202-8. doi: 10.1159/000213115. [PMID: 6852547]
  • G M Thoms, I J Reece, N J Odom, C M Kaye, M G Sankey. Acebutolol and coronary artery surgery. Plasma levels following oral pre-operative treatment. Anaesthesia. 1982 Nov; 37(11):1078-83. doi: 10.1111/j.1365-2044.1982.tb01751.x. [PMID: 6982635]
  • B Flouvat, A Roux, B Delhotal, D Lemaigre, M Leroy, F Liot. The beta-blocking effect of diacetolol in humans and its relationship to plasma levels. International journal of clinical pharmacology, therapy, and toxicology. 1982 Aug; 20(8):358-61. doi: NULL. [PMID: 6126441]
  • W Kirch, H Köhler, G Berggren, W Braun. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite. Clinical nephrology. 1982 Aug; 18(2):88-94. doi: NULL. [PMID: 7140021]
  • M Thibonnier, C Flabeau, M Thouvenin, A Roux, B Flouvat, P Pasquier, J Menard. Antihypertensive effect of diacetolol in essential hypertension. British journal of clinical pharmacology. 1982 Apr; 13(4):533-7. doi: 10.1111/j.1365-2125.1982.tb01417.x. [PMID: 6121577]
  • K Ohashi, S J Warrington, C M Kaye, G W Houghton, M Dennis, R Templeton, P Turner. Observations on the clinical pharmacology and plasma concentrations of diacetolol, the major human metabolite of acebutolol. British journal of clinical pharmacology. 1981 Oct; 12(4):561-5. doi: 10.1111/j.1365-2125.1981.tb01265.x. [PMID: 7295489]
  • B Gourmel, J Fiet, R F Collins, J M Villette, P Passa, C Dreux. Plasma diacetolol assessment by radioimmunoassay. Clinica chimica acta; international journal of clinical chemistry. 1981 Sep; 115(2):299-34. doi: 10.1016/0009-8981(81)90079-6. [PMID: 7285368]
  • R Gabriel, C M Kaye, M G Sankey. Preliminary observations on the excretion of acebutolol and its acetyl metabolite in the urine and faeces of man. The Journal of pharmacy and pharmacology. 1981 Jun; 33(6):386-7. doi: 10.1111/j.2042-7158.1981.tb13811.x. [PMID: 6115014]
  • A A Gulaid, I M James, C M Kaye, O R Lewellen, E Roberts, M Sankey, J Smith, R Templeton, R J Thomas. The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.). Biopharmaceutics & drug disposition. 1981 Apr; 2(2):103-14. doi: 10.1002/bdd.2510020202. [PMID: 7248475]
  • B Flouvat, A Roux, N P Chau, M Viallet, X Andre-Fouet, R Woehrle, J Gregoire. Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol. European journal of clinical pharmacology. 1981 Mar; 19(4):287-92. doi: 10.1007/bf00562806. [PMID: 7286031]
  • S Munn, R R Bailey, E Begg, R Ebert, D G Ferry. Plasma and urine concentrations of acebutolol and its acetyl metabolite in patients with renal functional impairment. The New Zealand medical journal. 1980 Apr; 91(658):289-91. doi: NULL. [PMID: 6930006]
  • T J Coombs, C J Coulson, V J Smith. Blood plasma binding of acebutolol and diacetolol in man. British journal of clinical pharmacology. 1980 Apr; 9(4):395-7. doi: 10.1111/j.1365-2125.1980.tb01067.x. [PMID: 7378256]